Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134081 · ClinicalTrials.gov registry record · NA
Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts
A NA study of Gingival Recession, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT01134081: Completed NA study of Gingival Recession, sponsored by University of Michigan.
NCT01134081 is a NA study of Gingival Recession that has completed, run by University of Michigan. The registered enrollment target is 44 participants, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01134081, a NA study of Gingival Recession, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational research study is to understand more about wound healing of gum tissue. This study was the biomarker study of a small cohort of study participants derived from NCT01547962 (completed). Two surgical sites of each patient were randomly selected to receive CelTx™ as a donor material in one site and conventional autograft using keratinized tissue from the palate as the donor material at the contralateral (opposite side) site. Fluids collected from between a tooth and the gum and directly from wounds contain proteins that occur in different levels as the wound healing process proceeds. In this research study wound fluid will be collected from the donor palate site (roof of your mouth) and the treated sites on your gum before and after placement of CelTx and conventional treatment (tissue from the roof of your mouth) to measure which proteins and how much of each are present during the first 4 weeks of wound healing.
Primary Outcome
Within-subject difference between the concentrations at the CelTX and Free Gingival Graft areas
Conditions Studied
Interventions
- BIOLOGICAL CelTx™
- PROCEDURE Free Gingival Graft
Study Locations (1)
Michigan
- Michigan Center for Oral Health Research - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT01134081 record still lists
NCT01134081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, above the 29-participant average among 10 other Gingival Recession trials with a reported enrollment target (52% higher).
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which CelTx™ is the first listed.
NCT01134081 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01134081 about?
NCT01134081 is a clinical study titled "Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts". The purpose of this observational research study is to understand more about wound healing of gum tissue. This study was the biomarker study of a small cohort of study participants derived from NCT01547962 (completed). Two surgical sites of each patient were randomly selected to receive CelTx™ as a ...
What is the current status of trial NCT01134081?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2008-01. Estimated completion is 2008-12.
What conditions does trial NCT01134081 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT01134081?
The interventions under investigation include: CelTx™ (BIOLOGICAL), Free Gingival Graft (PROCEDURE).
Who is sponsoring clinical trial NCT01134081?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01134081 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01134081's enrollment target sits among peer trials
44 2nd of 10 the highest of 10 other Gingival Recession trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingival Recession trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Thick vs. Thin Acellular Dermal Matrix (ADM)
COMPLETED · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia